Endocrine therapy of breast cancer, 2.. Current developments and new methodologies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783540183396
3540183396
- Umfang
-
65 S.
- Sprache
-
Englisch
- Anmerkungen
-
graph. Darst.
Literaturangaben
- Erschienen in
-
Endocrine therapy of breast cancer
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin, Heidelberg [u.a.]
- (wer)
-
Springer
- (wann)
-
1987
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Springer
Entstanden
- 1987
Ähnliche Objekte (12)
![Endocrine therapy of breast cancer, [1]](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Endocrine therapy of breast cancer, [1]
Endocrine therapy of breast cancer, 3
Endocrine therapy and growth regulation of breast cancer
GLYATL1 PROMOTES ENDOCRINE THERAPY RESISTANCE IN BREAST CANCER
Endocrine therapy of breast cancer, 4.. / A. Goldhirsch (Ed.)
Clonal heterogeneity of endocrine therapy resistance in breast cancer
Endocrine therapy of breast cancer : experimental and clin. aspects
Endocrine therapy of breast cancer, 5.. / A. Goldhirsch (Ed.)
Breast cancer and endocrine therapy adherence in Ethiopia : diagnosis, treatment, and breast nurse intervention
KCa channels in breast cancer development, progression and response to endocrine and radiation therapy
Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early breast cancer
Breast diseases : breast-conserving therapy, non-invasive therapy, mastopathy
Endocrine therapy of breast cancer, [1]
Endocrine therapy of breast cancer, 3
Endocrine therapy and growth regulation of breast cancer
GLYATL1 PROMOTES ENDOCRINE THERAPY RESISTANCE IN BREAST CANCER
Endocrine therapy of breast cancer, 4.. / A. Goldhirsch (Ed.)
Clonal heterogeneity of endocrine therapy resistance in breast cancer
Endocrine therapy of breast cancer : experimental and clin. aspects
Endocrine therapy of breast cancer, 5.. / A. Goldhirsch (Ed.)
Breast cancer and endocrine therapy adherence in Ethiopia : diagnosis, treatment, and breast nurse intervention
KCa channels in breast cancer development, progression and response to endocrine and radiation therapy
Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early breast cancer
Breast diseases : breast-conserving therapy, non-invasive therapy, mastopathy
Endocrine therapy of breast cancer, [1]
Endocrine therapy of breast cancer, 3
Endocrine therapy and growth regulation of breast cancer
GLYATL1 PROMOTES ENDOCRINE THERAPY RESISTANCE IN BREAST CANCER
Endocrine therapy of breast cancer, 4.. / A. Goldhirsch (Ed.)
Clonal heterogeneity of endocrine therapy resistance in breast cancer
Endocrine therapy of breast cancer : experimental and clin. aspects
Endocrine therapy of breast cancer, 5.. / A. Goldhirsch (Ed.)
Breast cancer and endocrine therapy adherence in Ethiopia : diagnosis, treatment, and breast nurse intervention
KCa channels in breast cancer development, progression and response to endocrine and radiation therapy
Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early breast cancer